LARVOL, a providesr of SaaS solutions to support the data and intelligence needs of the pharmaceutical and biotech industry, announced on Tuesday that it has appointed Mark Lagunowich as vice president, Global Sales.
With more that 30 years of experience in the life science industry, Lagunowich most recently led the Americas Life Science Sales Team for Clarivate Analytics.
Previously, Lagunowich worked as Global VP of Sales at Sparta Systems for eight years, selling a wide variety of business solutions to pharmaceutical, medical device, and clinical research (CRO) companies.
Lagunowich's appointment adds to several important new hires for LARVOL, including HR and Marketing leadership roles, as the company prepares to launch additional oncology-focused solutions in 2021. These include VIEW, a social listening platform aimed at capturing the conversations of oncology opinion leaders on Twitter, which will launch at ScaleUp 360 in April, along with CLIN, a complete database of immuno-oncology clinical trial data that will also launch in spring this year.
Telix Pharmaceuticals delivers first commercial doses from Belgian manufacturing hub
Innovent presents mazdutide Phase 3 clinical study results at ADA 85th Scientific Sessions
Hoth Therapeutics reports positive interim results for HT-001 topical therapy
Aiforia Technologies launches CE-IVD marked AI solution for breast cancer diagnostics
Stockholders approve proposed merger of TuHURA Biosciences and Kineta
Sarclisa recommended for EU approval in newly diagnosed transplant-eligible multiple myeloma
Harbour BioMed and Otsuka collaborate on advancing BCMAxCD3 bispecific T-cell engagers
Dizal completes enrolment in sunvozertinib vs. platinum doublet phase III study
RyboDyn joins Lilly Gateway Labs' innovation hub
GRAIL reports positive results from Galleri multi-cancer early detection test registrational study